Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs WOCKHARDT - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA WOCKHARDT AUROBINDO PHARMA/
WOCKHARDT
 
P/E (TTM) x 20.9 -14.7 - View Chart
P/BV x 2.2 2.3 92.6% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 AUROBINDO PHARMA   WOCKHARDT
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-23
WOCKHARDT
Mar-23
AUROBINDO PHARMA/
WOCKHARDT
5-Yr Chart
Click to enlarge
High Rs715316 226.5%   
Low Rs397145 273.3%   
Sales per share (Unadj.) Rs424.2184.0 230.6%  
Earnings per share (Unadj.) Rs32.9-43.1 -76.3%  
Cash flow per share (Unadj.) Rs54.1-25.7 -210.8%  
Dividends per share (Unadj.) Rs3.000-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs458.1231.7 197.7%  
Shares outstanding (eoy) m585.94144.09 406.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.31.3 104.6%   
Avg P/E ratio x16.9-5.3 -316.1%  
P/CF ratio (eoy) x10.3-9.0 -114.4%  
Price / Book Value ratio x1.21.0 122.0%  
Dividend payout %9.10-   
Avg Mkt Cap Rs m325,75333,202 981.1%   
No. of employees `000NANA-   
Total wages/salary Rs m35,2236,370 552.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m248,55426,510 937.6%  
Other income Rs m2,9061,220 238.2%   
Total revenues Rs m251,46027,730 906.8%   
Gross profit Rs m37,070-1,930 -1,920.7%  
Depreciation Rs m12,4462,510 495.8%   
Interest Rs m1,4053,020 46.5%   
Profit before tax Rs m26,125-6,240 -418.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,849-30 -22,828.3%   
Profit after tax Rs m19,277-6,210 -310.4%  
Gross profit margin %14.9-7.3 -204.9%  
Effective tax rate %26.20.5 5,452.6%   
Net profit margin %7.8-23.4 -33.1%  
BALANCE SHEET DATA
Current assets Rs m214,59919,140 1,121.2%   
Current liabilities Rs m114,93834,350 334.6%   
Net working cap to sales %40.1-57.4 -69.9%  
Current ratio x1.90.6 335.1%  
Inventory Days Days2139 52.4%  
Debtors Days Days6611 597.7%  
Net fixed assets Rs m176,66848,670 363.0%   
Share capital Rs m586720 81.4%   
"Free" reserves Rs m267,81332,660 820.0%   
Net worth Rs m268,39933,380 804.1%   
Long term debt Rs m6,1902,240 276.3%   
Total assets Rs m392,12570,750 554.2%  
Interest coverage x19.6-1.1 -1,838.0%   
Debt to equity ratio x00.1 34.4%  
Sales to assets ratio x0.60.4 169.2%   
Return on assets %5.3-4.5 -117.0%  
Return on equity %7.2-18.6 -38.6%  
Return on capital %10.0-9.0 -110.9%  
Exports to sales %33.70-   
Imports to sales %15.33.5 441.2%   
Exports (fob) Rs m83,703NA-   
Imports (cif) Rs m38,060920 4,136.9%   
Fx inflow Rs m85,483730 11,710.0%   
Fx outflow Rs m41,447920 4,505.1%   
Net fx Rs m44,036-190 -23,176.8%   
CASH FLOW
From Operations Rs m23,8681,530 1,560.0%  
From Investments Rs m-39,778-1,250 3,182.2%  
From Financial Activity Rs m18,144-3,150 -576.0%  
Net Cashflow Rs m2,298-2,800 -82.1%  

Share Holding

Indian Promoters % 48.8 54.9 88.8%  
Foreign collaborators % 3.1 0.0 -  
Indian inst/Mut Fund % 41.3 4.5 922.3%  
FIIs % 20.7 4.2 496.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 45.1 106.9%  
Shareholders   241,944 161,813 149.5%  
Pledged promoter(s) holding % 20.1 74.5 27.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Aurobindo Pharma vs Wockhardt

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Aurobindo Pharma vs Wockhardt Share Price Performance

Period Aurobindo Pharma Wockhardt S&P BSE HEALTHCARE
1-Day -2.40% 1.36% -0.95%
1-Month -4.56% -1.62% -5.00%
1-Year 109.39% 221.42% 57.50%
3-Year CAGR 6.45% 11.61% 18.15%
5-Year CAGR 5.01% 6.45% 18.88%

* Compound Annual Growth Rate

Here are more details on the Aurobindo Pharma share price and the Wockhardt share price.

Moving on to shareholding structures...

The promoters of Aurobindo Pharma hold a 51.8% stake in the company. In case of Wockhardt the stake stands at 54.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Aurobindo Pharma and the shareholding pattern of Wockhardt.

Finally, a word on dividends...

In the most recent financial year, Aurobindo Pharma paid a dividend of Rs 3.0 per share. This amounted to a Dividend Payout ratio of 9.1%.

Wockhardt paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of Aurobindo Pharma, and the dividend history of Wockhardt.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3% Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3%(10:30 am)

Asian shares slipped before a Bank of Japan policy decision where authorities are likely to bring an end to the world's last negative rates regime.